Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is the most serious side effect in patients receiving bisphosphonates (BPs) for neoplastic disease and osteoporosis. The aim of this study is to propose a new dimensional stage classification, guiding the surgical treatment of BRONJ patients, and to evaluate the success rate of this new management. From 2004 to 2013, 203 neoplastic and osteoporotic patients with 266 BRONJ lesions were referred to the Odontostomatology Unit of the University of Bari. All patients underwent surgery after suspension of BPs therapy and antibiotic treatment. The surgical procedure was complemented by piezosurgery and followed by the application of hyaluronate and amino acids. The new dimensional staging sug...
Background/PurposeBisphosphonates (BPs) are used to treat osteoporosis and bone metastases from mali...
Bisphosphonate-related Osteonecrosis of the Jaw (BRONJ) is a condition which, according to the Ameri...
In 2014, the nomenclature of bisphosphonate-related osteonecrosis of the jaw (BRONJ) was changed in ...
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is the most serious side effect in patients ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Recently, jawbone osteonecrosis has been largely reported as a potential adverse effect of bisphosph...
Purpose: The aim of this study was to evaluate the results of the surgical treatment of bisphosphona...
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is an extremely therapy resistant osteomyel...
Aims. Bisphosphonates (BPs) are important therapeutic drugs in multiple myeloma and cancers with bo...
Bisphosphonates (BPs) are a class of drugs used to treat osteoporosis and malignant bone metastasis....
Objectives: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a relatively rare but serious...
Chemotherapy-associated osteonecrosis of the jaw caused by bisphosphonates is an exposure of necroti...
Bisphosphonates (BPs) are now widely used to treat various skeletal complications. Although the numb...
Aims: To determine the success rates of the surgical and non-surgical treatments in the management o...
Bisphosphonates are a class of agents used to treat osteoporosis and malignant bone metastases. Desp...
Background/PurposeBisphosphonates (BPs) are used to treat osteoporosis and bone metastases from mali...
Bisphosphonate-related Osteonecrosis of the Jaw (BRONJ) is a condition which, according to the Ameri...
In 2014, the nomenclature of bisphosphonate-related osteonecrosis of the jaw (BRONJ) was changed in ...
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is the most serious side effect in patients ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Recently, jawbone osteonecrosis has been largely reported as a potential adverse effect of bisphosph...
Purpose: The aim of this study was to evaluate the results of the surgical treatment of bisphosphona...
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is an extremely therapy resistant osteomyel...
Aims. Bisphosphonates (BPs) are important therapeutic drugs in multiple myeloma and cancers with bo...
Bisphosphonates (BPs) are a class of drugs used to treat osteoporosis and malignant bone metastasis....
Objectives: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a relatively rare but serious...
Chemotherapy-associated osteonecrosis of the jaw caused by bisphosphonates is an exposure of necroti...
Bisphosphonates (BPs) are now widely used to treat various skeletal complications. Although the numb...
Aims: To determine the success rates of the surgical and non-surgical treatments in the management o...
Bisphosphonates are a class of agents used to treat osteoporosis and malignant bone metastases. Desp...
Background/PurposeBisphosphonates (BPs) are used to treat osteoporosis and bone metastases from mali...
Bisphosphonate-related Osteonecrosis of the Jaw (BRONJ) is a condition which, according to the Ameri...
In 2014, the nomenclature of bisphosphonate-related osteonecrosis of the jaw (BRONJ) was changed in ...